Results

Total Results: 4,578 records

Showing results for "percentages".

4461. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
      September 30, 2024 - Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement Screening for Breast Cancer US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Summary of Recommendations See the Summary of Recommendations figure. IMPORTANCE Among all US women, breas…

4462. Evidence Summary: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
      July 26, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions…

4463. Disposition of Comments for CER 159 Insomnia (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
      December 30, 2015 - Disposition of Comments for CER 159 Insomnia Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Management of Insomnia Disorder Draft review available for public comment from November, 2014 to December 2014. Research Review Citation: Brasure M, MacDonald R, Fuchs…

4464. Peripheral-Artery-Disease-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
      May 01, 2013 - 1 Treatment Strategies for Patients With Peripheral Artery Disease Executive Summary Background Peripheral artery disease (PAD) refers to chronic narrowing or atherosclerosis of the lower extremities1 and represents a spectrum of disease severity from asymptomatic disease to intermittent claudication (IC), to …

4465. Physical Therapy for Knee Pain Secondary to Osteoarthritis Disposition of Comment Report (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_disposition-comments.pdf
      November 06, 2012 - Physical Therapy for Knee Pain Secondary to Osteoarthritis Disposition of Comment Report Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1285 Published Online: November 6, 2012 Comparative Effectiveness Research Review Disposition of Co…

4466. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
      January 01, 2015 - GlaxoSmithKline Results The lost to follow-up for Ahren et al (reference 110) is reported as various percentages

4467. Disposition of Comments Report for Technical Brief 14 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
      March 18, 2014 - Table 9 has too much precision for percentages.

4468. Antiplatelet-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
      September 01, 2013 - 1 Comparative Effectiveness Review Number 125 Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment Executive Summary Background Burden of Disease and Clinical Setting Approximately 82 million Americans currently suffer from some form of cardiovascular disease.1 In the United …

4469. Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2024 National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
      hcup-us.ahrq.gov/reports/methods/MS2024-01-NHQDRMethodsReport.pdf
      November 25, 2024 - Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2024 National Healthcare Quality and Disparities Report (NHQDR) HCUP Methods Series Methods Report Describing 2016-2021 HCUP Data in the National Healthcare Quality and Disparities Report (NHQDR) Report #202…

4470. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
      March 15, 2007 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary: NSAIDs Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication March 15, 2007 Recommendations made by the USPSTF are independen…

4471. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
      March 01, 2007 - Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task For…

4472. Cerebral-Palsy-Feeding Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
      March 01, 2013 - 1 Comparative Effectiveness Review Number 94 Interventions for Feeding and Nutrition in Cerebral Palsy Executive Summary Background Cerebral palsy (CP) is a “group of disorders of the development of movement and posture, causing activity limitation, that is attributed to non-progressive disturbances that…

4473. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/palliative-care-tools-disposition.pdf
      May 04, 2017 - Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care Technical Brief Disposition of Comments Report Research Review Title: Assessment Tools for Palliative Care Draft review available for public comment from August 25, 2016 September 21, 2016. Research Review Citation: …

4474. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/palliative-care-tools-disposition.pdf
      May 04, 2017 - Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care Technical Brief Disposition of Comments Report Research Review Title: Assessment Tools for Palliative Care Draft review available for public comment from August 25, 2016 September 21, 2016. Research Review Citation: …

4475. Evaluation of Stage 3 Meaningful Use Objectives: Pennsylvania and Utah (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/evaluation-stage-3-meaningful-use-pa-ut-final-report.pdf
      February 01, 2015 - Evaluation of Stage 3 Meaningful Use Objectives: Pennsylvania and Utah FINAL CONTRACT REPORT Evaluation of Stage 3 Meaningful Use Objectives: Pennsylvania and Utah Agency for Healthcare Research and Quality Advancing Excellence in Health Care www.ahrq.gov HEALTH IT DC PR …

4476. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
      September 01, 2011 - Layout 1 Background Antipsychotics medications are approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder. These medications are commonly divided into two classes, reflecting two waves of historical development: the conventional antipsychotics and the atypical. T…

4477. D_ITPrivacyandSecurityPrimer (pdf file)
      digital.ahrq.gov/sites/default/files/docs/page/D_ITPrivacyandSecurityPrimer_1.pdf
      March 20, 1997 - D_ITPrivacyandSecurityPrimer Appendix D: IT Privacy and Security Primer PART 1: GENERAL PRIVACY CONSIDERATIONS1 Introduction The purpose of this IT Privacy and Security Primer is to provide a broad overview of what privacy in health care represents. This section is not intended to address the state a…

4478. Redesigning Systems To Improve Teamwork and Quality for Hospitalized Patients: RESET Project Implementation Guide (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reset-guide.pdf
      January 01, 2020 - Redesigning Systems To Improve Teamwork and Quality for Hospitalized Patients: RESET Project Implementation Guide REdesigning SystEms to Improve Teamwork and Quality for Hospitalized Patients: RESET Project Implementation Guide Prepared by the RESET Investigators Version 2.0: September 2019 Funded by …

4479. Evidence Summary: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
      August 22, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Prevention of Acquisition of HIV: Preexposure Prophylaxis August 22, 2023 Recommendations made by the USPSTF are independent of the U.S. government. They sh…

4480. 8Lbrrlzvtemzycdnsjtokz (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/8LBrrLzvtemZYcdNSjToKz
      December 01, 2014 - Behavioral Sexual Risk-Reduction Counseling in Primary Care to Prevent Sexually Transmitted Infections: A Systematic Review for the U.S. Preventive Services Task Force Elizabeth A. O’Connor, PhD; Jennifer S. Lin, MD, MCR; Brittany U. Burda, MPH; Jillian T. Henderson, PhD; Emily S. Walsh, MPH; and Evelyn P. Whitlock, MD…